Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

However, considering the infections occurred within the first year of therapy, we noticed that patients with infection (5.2%) showed at the baseline, a lower number of white blood cells compared to “infections‐free patients” (5735.56 ± 1433.4 and 6982 ± 2057.83, respectively) and a lower number of lymphocytes (1717.8 ± 380.4 and 2116.6 ± 681.5, respectively), but these differences did not reach statistical significance .

also in 111,027 other papers